| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |